APA (7th ed.) Citation

CP, B., T, B., TE, C., M, K., SH, Y., F, F., . . . CC, Z. (2012). Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): Results from a randomised, double-blind, phase 3 study. Lancet Oncology, 13(3), 292.

Chicago Style (17th ed.) Citation

CP, Belani, et al. "Quality of Life in Patients with Advanced Non-small-cell Lung Cancer Given Maintenance Treatment with Pemetrexed Versus Placebo (H3E-MC-JMEN): Results from a Randomised, Double-blind, Phase 3 Study." Lancet Oncology 13, no. 3 (2012): 292.

MLA (9th ed.) Citation

CP, Belani, et al. "Quality of Life in Patients with Advanced Non-small-cell Lung Cancer Given Maintenance Treatment with Pemetrexed Versus Placebo (H3E-MC-JMEN): Results from a Randomised, Double-blind, Phase 3 Study." Lancet Oncology, vol. 13, no. 3, 2012, p. 292.